The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis

OBJECTIVES: To evaluate the efficacy of immuno-oncology combinational therapy (IOCT) versus monotherapy with programmed cell death 1 (PD-1) or PD-ligand 1 (PD-L1) inhibitors or conventional therapies, i.e., non-IOCT, in patients with advanced solid tumors. METHODS: We systematically searched the Pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Run-Cong, Zhao, Chong-Bang, Xia, Xiao-Wei, Luo, Ying-Shan, Wu, Ting, Zhou, Zhi-Wei, Yuan, Shu-Qiang, Wang, Yun, Li, Yuan-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225910/
https://www.ncbi.nlm.nih.gov/pubmed/32461994
http://dx.doi.org/10.1155/2020/5059079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225910/
https://www.ncbi.nlm.nih.gov/pubmed/32461994
http://dx.doi.org/10.1155/2020/5059079

Ejemplares similares